为促进海洋生物医药产业资源要素的优化配置,从自然资源、人力资源、资本投入、科学技术和政府政策五个方面选取要素指标,进行灰色关联度分析,以此构建海洋生物医药产业资源要素配置效率评价指标体系,并通过构建CCR- BCC交叉评价模型对2006-2015年间中国沿海11省市(不包括港澳台)海洋生物医药产业资源要素配置效率进行定量测算与等级划分。结果显示：政府资金投入、海洋药物研发经费投入、海洋经济生产总值是影响海洋生物医药产业发展的主要因素,此外,中国沿海11省市海洋生物医药产业资源要素配置效率存在显著的差异,可以划分为4个等级,第1等级有浙江、山东和广东,第2等级有江苏、上海和辽宁,第3等级有福建、天津和河北,第4等级有广西、海南。

This study selects factor indicators from the five aspects of natural resources, human resources, capital investment, science and technology, and government policy to do Grey Correlation Analysis, so as to construct the evaluation index system of resource allocation efficiency of marine biopharmaceutical industry. Then the quantitative analysis and classification of resource allocation efficiency of marine biopharmaceutical industry in China"s coastal provinces were carried out fron 2006 to 2015, through the constructed CCR-BCC cross-evaluation model. The results show that government investment, marine drug R D investment and marine economic gross product are the main factors affecting the development of marine biopharmaceutical industry. In addition, there are significant differences in resource allocation efficiency of marine biomedical industry in coastal areas. It can be divided into four levels: the first level is Zhejiang, Guangdong and Shandong, the second level is Jiangsu, Shanghai and Liaoning, the third level is Fujian, Tianjin and Hebei, and the fourth level is Guangxi and Hainan.

F602.9

国家自然科学基金重点项目“基于化学生态效应的珊瑚礁药用生物新资源发现”(41830535)；项目来源：国家海洋局软科学项目“海洋强国战略背景下我国海洋产业发展路径研究”(G.2200204.150201)；自然资源部海洋战略规划与经济司项目“我国海洋生物医药产业发展新路径研究”(GAMA201817)。